公司概覽
業務類別 --
業務概覽 Takara Bio Inc is a biotechnology company that develops gene therapy procedures. The company reports in three business segments: Bioindustry, Gene therapy, and AgriBio. Takara's bioindustry business provides research reagents, scientific instruments, and various contracted services to universities and companies around the world. The company's gene therapy business is focused on treating cancer and HIV. Its AgriBio business aims to leverage biotechnologies in the food ingredient field, including large-scale mushroom production. The vast majority of Takara's revenue is derived from its bioindustry segment.
公司地址 Nojihigashi 7-4-38 Kusatu, Shiga, Otsu, JPN, 520-0058
電話號碼 +81 775656920
傳真號碼 --
公司網頁 http://www.takara-bio.co.jp
員工數量 1453
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Yoh Hamaoka Director, Senior Managing Director, Senior Managing Executive Officer and General Manager, Corporate Division -- 20/06/2025
Mr. Katsuhiko Kusakabe Director, Senior Managing Director, Senior Managing Executive Officer, Chief Manufacturing Control Officer and General Manager, Management Headquarters -- 20/06/2025
Mr. Junichi Mineno Director, Vice President, General Manager, CDM Promotion Division and Vice President Executive Officer -- 20/06/2025
Mr. Koichi Nakao Director, President, Chief Executive Officer and Executive Officer -- 20/06/2025
Mr. Tsuyoshi Miyamura Director, Senior Managing Director and Senior Managing Executive Officer -- 20/06/2025
 
董事會成員
董事會 職務 更新日期
Mr. Noriomi Matsumura Independent Director 20/06/2025
Mr. Yoh Hamaoka Director, Senior Managing Director, Senior Managing Executive Officer and General Manager, Corporate Division 20/06/2025
Ms. Kazuko Kimura Independent Director 20/06/2025
Mr. Katsuhiko Kusakabe Director, Senior Managing Director, Senior Managing Executive Officer, Chief Manufacturing Control Officer and General Manager, Management Headquarters 20/06/2025
Mr. Junichi Mineno Director, Vice President, General Manager, CDM Promotion Division and Vice President Executive Officer 20/06/2025
Ms. Nobuko Kawashima Independent Director 20/06/2025
Mr. Koichi Nakao Director, President, Chief Executive Officer and Executive Officer 20/06/2025
Mr. Tsuyoshi Miyamura Director, Senior Managing Director and Senior Managing Executive Officer 20/06/2025
Mr. Mutsumi Kimura Director 20/06/2025
 
所屬ETF (更新日期: 07/03/2026 03:12)
代號 名稱 佔比% 持有日期
IEFAiShares Core MSCI EAFE ETF0.23%28/02/2026
SCZiShares MSCI EAFE Small-Cap ETF0.17%28/02/2026
DXJWisdomTree Japan Hedged Equity ETF0.15%27/02/2026
DFISDimensional International Small Cap ETF0.14%27/02/2026
IXUSiShares Core MSCI Total Intl Stk ETF0.12%28/02/2026
SCHCSchwab International Small-Cap Eq ETF™0.08%28/02/2026
DFICDimensional International Core Eq 2 ETF0.07%27/02/2026
DFJWisdomTree Japan SmallCap Dividend ETF0.04%27/02/2026
IDEViShares Core MSCI Intl Dev Mkts ETF0.04%28/02/2026
SPDWState Street® SPDR® Ptf Dev Wld exUS ETF0.03%27/02/2026
DFAIDimensional International Cr Eq Mkt ETF0.03%27/02/2026
DDWMWisdomTree Dynamic International Eq ETF0.03%27/02/2026
DFAXDimensional World ex US Core Eq 2 ETF0.02%27/02/2026
GWXState Street® SPDR® S&P® Intl Sm Cp ETF0.02%27/02/2026
VTVanguard Total World Stock ETF0.02%31/01/2026
DWMWisdomTree International Equity ETF0.01%27/02/2026
TLTDFlexShares Mstar DevMks exUS FctTilt ETF0.01%27/02/2026
GINNGoldman Sachs Innovate Equity ETF0.01%27/02/2026
IPACiShares Core MSCI Pacific ETF0.01%28/02/2026
SCJiShares MSCI Japan Small-Cap ETF0.01%28/02/2026
 1    2  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.